Not to be outdone by its proteo-centric Ivy League neighbors to the north, namely Harvard, the University of Pennsylvania is embarking on its own effort to build a comprehensive core facility for proteomics research. The university has yet to allocate a specific space for the new 2,500 square foot facility, but has pledged $5 million for the future purchase of 2D gel and mass spectrometry equipment, said Ian Blair, a professor of pharmacology at the university and the director of the core proteomics facility.